Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-048335
Filing Date
2017-09-15
Accepted
2017-09-15 20:11:26
Documents
1
Period of Report
2017-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 v475285_form4.html 4  
1 FORM 4 v475285_form4.xml 4 18266
  Complete submission text file 0001144204-17-048335.txt   19909
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 WEST 96TH STREET APT. 11C NEW YORK NY 10025
Business Address
Johnson Richard G (Reporting) CIK: 0001601338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 171088838